Summary | The developer plans to enroll 750 patients in the
phase III trial in China, the US and Europe.It will take three
to four years to plete at a cost of some 50 million US
dollars.FDA reviewed the materials of proof of safety submitted
by the pany.Kanglaite has been widely used by patients in China
since it was certified in 1995.Intellectual property protection ...
en.ce.cn | 05 July 2015